Maxwell Biosciences
Austin, US · Delaware corporation · 4 known investors
Maxwell Biosciences develops therapeutics aimed at treating infectious diseases. The company works with research and defense institutions on biodefense and antimicrobial-related work.
AI & Machine LearningBiotechHealthtechLongevity
Founders & leadership
JM
Joshua McClureFounder
KM
Kate McKinleyinNamed on SEC filing
PT
Praveen TyleNamed on SEC filing
BR
Barbara R HolcombNamed on SEC filing
AB
Annelise BarronNamed on SEC filing
Investors · 4
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 1 of 2 rounds · 2021–2023
▶$25MofferedJul 2023 · BiotechnologyRule 506(b)
▶$25MofferedJul 2023 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joshua McClureExecutive Officer, Director, Promoter
- Kate McKinleyDirector
- Praveen TyleDirector
- Barbara R HolcombDirector
- Annelise BarronDirector
- Offering amount
- $25M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.9MraisedApr 2022 · 96 investors · BiotechnologyRule 506(b)
▶$10.9MraisedApr 2022 · 96 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Praveen TyleDirector
- Annelise BarronDirector
- Theodore MoskovitzDirector
- Christopher JohnsDirector
- Joshua McClureExecutive Officer, Director
- Offering amount
- $14.8M
- Amount sold
- $10.9M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapIQVIA17 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Bioworld15 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Maxwell Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $256.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Maxwell Biosciences do?
- Maxwell Biosciences develops therapeutics aimed at treating infectious diseases. The company works with research and defense institutions on biodefense and antimicrobial-related work.
- Who founded Maxwell Biosciences?
- Maxwell Biosciences was founded by Joshua McClure.
- Who are Maxwell Biosciences's investors?
- Maxwell Biosciences's investors include Capital Factory, Das & Co., Keiretsu Forum, LoftyInc Capital.
- How much funding has Maxwell Biosciences raised?
- Maxwell Biosciences has disclosed $10.9M raised across 1 of its 2 known rounds.
- Where is Maxwell Biosciences headquartered?
- Maxwell Biosciences is headquartered in Austin, US.